MOOG Medical Devices Group, Curlin Infusion Administration Sets: Class I Recall - Potential for Reverse Flow of Fluid

June 1, 2012, 8:00 am by Safety Alerts

Device malfunction may cause blood loss, an under-delivery of prescribed medicines or fluids, or a potential delay in therapy, leading to serious adverse health consequences, including death.

Read the full article

More from Safety Alerts

Compounded Prescription Therapies By Pentec Health Inc.: Recall - Lack Of Sterility Assurance
Safety Alerts : May 17, 2013, 3:55 am
Patients are at increased risk of infection in the event a sterile product is compromised.

Atriphen dietary supplement (Xymogen brand): Recall - Potential Allergic Reaction Due to Milk and Soy
Safety Alerts : May 9, 2013, 4:00 am
Risk of serious or life-threatening allergic reaction.

SexVoltz, Velextra, and Amerect by Beomonstar Products: Recall - Undeclared Drug Ingredient
Safety Alerts : May 8, 2013, 9:30 am
Undeclared tadalafil may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels.

The Compounding Shop: FDA News Release - Lack of Sterility Assurance of Drug Products
Safety Alerts : May 8, 2013, 5:45 am
These products should not be administered to patients. If a drug product marketed as sterile has microbial contamination, it potentially places patients at risk of serious infection.

Covidien Surgical Stapler Reloads: FDA Safety Communication - Devices Stolen Before They Were Sterilized
Safety Alerts : May 7, 2013, 12:15 pm
Use of these non-sterile products could increase the risk of infection in surgical patients.